Rhonda Patrick· PhD
So they had lower amaloid beta in their in in their plasma but they also had increased markers of neuronal autophagy.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So they had lower amaloid beta in their in in their plasma but they also had increased markers of neuronal autophagy.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
These patients had uh mild cognitive impairment and they took two grams a day of omega-3 for two years and after the two years they had improvements in cognitive function, executive function um and importantly they actually had lower plasma biomarkers of Alzheimer's disease.